Ely Benaim is Chief Medical Officer of NovoCure Ltd. Currently has a direct ownership of 28,770 shares of NVCR, which is worth approximately $923,517. The most recent transaction as insider was on Jan 06, 2023, when has been sold 98 shares (Ordinary Shares) at a price of $62.3 per share, resulting in proceeds of $6,105. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.8K
0% 3M change
0% 12M change
Total Value Held $923,517

Ely Benaim Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2023
BUY
Grant, award, or other acquisition
$6,105 $62.3 p/Share
98 Added 0.34%
28,770 Ordinary Shares
Aug 03 2022
SELL
Open market or private sale
$432,266 $72.54 p/Share
5,959 Reduced 17.21%
28,672 Ordinary Shares
Aug 02 2022
SELL
Open market or private sale
$30,441 $69.66 p/Share
437 Reduced 1.25%
34,631 Ordinary Shares
Jul 05 2022
BUY
Grant, award, or other acquisition
$13,116 $59.08 p/Share
222 Added 0.63%
35,068 Ordinary Shares
May 11 2022
SELL
Open market or private sale
$130,769 $61.25 p/Share
2,135 Reduced 5.77%
34,846 Ordinary Shares
May 10 2022
SELL
Open market or private sale
$134,881 $65.16 p/Share
2,070 Reduced 5.3%
36,981 Ordinary Shares
Mar 04 2022
SELL
Open market or private sale
$106,319 $70.41 p/Share
1,510 Reduced 3.37%
43,257 Ordinary Shares
Mar 03 2022
SELL
Open market or private sale
$59,824 $74.5 p/Share
803 Reduced 1.76%
44,767 Ordinary Shares
Mar 03 2022
BUY
Grant, award, or other acquisition
-
17,371 Added 27.6%
45,570 Ordinary Shares
Jan 06 2022
BUY
Grant, award, or other acquisition
$3,510 $63.82 p/Share
55 Added 0.19%
28,199 Ordinary Shares
Aug 03 2021
SELL
Open market or private sale
$69,651 $150.11 p/Share
464 Reduced 1.62%
28,144 Ordinary Shares
Aug 02 2021
SELL
Open market or private sale
$80,068 $149.38 p/Share
536 Reduced 1.84%
28,608 Ordinary Shares
Jul 30 2021
SELL
Open market or private sale
$103,483 $158.96 p/Share
651 Reduced 2.18%
29,144 Ordinary Shares
Jul 30 2021
BUY
Exercise of conversion of derivative security
$54,228 $83.3 p/Share
651 Added 2.14%
29,795 Ordinary Shares
Jul 06 2021
BUY
Grant, award, or other acquisition
$12,341 $137.12 p/Share
90 Added 0.31%
29,144 Ordinary Shares
May 27 2021
SELL
Open market or private sale
$366,600 $200.0 p/Share
1,833 Reduced 5.93%
29,054 Ordinary Shares
May 27 2021
BUY
Exercise of conversion of derivative security
$87,177 $47.56 p/Share
1,833 Added 5.6%
30,887 Ordinary Shares
May 12 2021
SELL
Open market or private sale
$350,673 $180.48 p/Share
1,943 Reduced 6.27%
29,054 Ordinary Shares
May 11 2021
SELL
Open market or private sale
$407,431 $180.12 p/Share
2,262 Reduced 6.8%
30,997 Ordinary Shares
May 10 2021
SELL
Open market or private sale
$347,628 $189.65 p/Share
1,833 Reduced 5.22%
33,259 Ordinary Shares
May 10 2021
BUY
Exercise of conversion of derivative security
$87,177 $47.56 p/Share
1,833 Added 4.96%
35,092 Ordinary Shares
Apr 13 2021
SELL
Open market or private sale
$1,191,600 $200.0 p/Share
5,958 Reduced 15.19%
33,259 Ordinary Shares
Apr 13 2021
BUY
Exercise of conversion of derivative security
$397,637 $66.74 p/Share
5,958 Added 13.96%
36,733 Ordinary Shares
Mar 05 2021
SELL
Open market or private sale
$383,805 $131.53 p/Share
2,918 Reduced 8.07%
33,259 Ordinary Shares
Mar 04 2021
SELL
Open market or private sale
$259,694 $137.55 p/Share
1,888 Reduced 4.96%
36,177 Restricted Share Units
EB

Ely Benaim

Chief Medical Officer
Malvern, PA

Track Institutional and Insider Activities on NVCR

Follow NovoCure Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVCR shares.

Notify only if

Insider Trading

Get notified when an Novo Cure LTD insider buys or sells NVCR shares.

Notify only if

News

Receive news related to NovoCure Ltd

Track Activities on NVCR